SCHEMBL7721995

SCHEMBL7721995

CC(C)(C)OC(=O)N1CC(CN(C=O)OC(C)(C)C)C[C@H]1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.34
TGM2 P21980 1/20 0.32
CYP1A2 P05177 1/20 0.31
POLB P06746 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C19 P33261 1/20 0.31
JAK2 O60674 1/20 0.31
JAK1 P23458 1/20 0.31
UCHL1 P09936 1/20 0.31
HTRA1 Q92743 1/20 0.31
CHRM2 P08172 1/20 0.30
CHRM1 P11229 1/20 0.30
CHRM3 P20309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7722084 1.00 NR1H2 (0.39) NR1H2SMN1; SMN2HSD17B10TGM2CYP1A2
SCHEMBL7729539 0.89 NR1H2 (0.38) NR1H2SMN1; SMN2TGM2CYP1A2POLB
SCHEMBL7721956 0.88 NR1H2 (0.37) NR1H2SMN1; SMN2TGM2CYP1A2POLB
SCHEMBL7729001 0.83 NR1H2 (0.44) NR1H2CHRM2CHRM1CHRM3
SCHEMBL3191040 0.78 NR1H2 (0.54) NR1H2SMN1; SMN2HSD17B10TGM2CYP1A2
SCHEMBL1645992 0.78 NR1H2 (0.43) NR1H2SMN1; SMN2HSD17B10TGM2CYP1A2
SCHEMBL1914761 0.78 NR1H2 (0.54) NR1H2SMN1; SMN2HSD17B10TGM2CYP1A2
SCHEMBL7807219 0.78 NR1H2 (0.54) NR1H2SMN1; SMN2HSD17B10TGM2CYP1A2
SCHEMBL1584533 0.78 NR1H2 (0.43) NR1H2SMN1; SMN2HSD17B10TGM2CYP1A2
SCHEMBL15817337 0.78 NR1H2 (0.43) NR1H2SMN1; SMN2HSD17B10TGM2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed
WO-2000001714-A1 EFFLUX PUMP INHIBITORS MICROCIDE PHARMACEUTICALS, INC. (US) 2000-01-13 WO disclosed